Supraventricular tachycardia medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Supraventricular tachycardia}} {{CMG}} ==Overview== ==Medical Therapy== ===Acute Treatment=== In general, SVT is not life threatening, but episodes should be t...")
 
(Moved physical maneuvers to its own page.)
 
(11 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Supraventricular tachycardia}}
{{Supraventricular tachycardia}}
{{CMG}}
{{CMG}}


==Overview==
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.


==Medical Therapy==
==Medical Therapy==
===Acute Treatment===
===Acute Treatment===
In general, SVT is not life threatening, but episodes should be treated or prevented.  While some treatment modalities can be applied to all SVTs with impunity, there are specific therapies available to cure some of the different sub-types.  Cure requires intimate knowledge of how and where the arrhythmia is initiated and propagated.
In general, [[SVT]] is not life threatening, but episodes should be treated or prevented.  While some treatment modalities can be applied to all SVTs with impunity, there are specific therapies available to cure some of the different sub-types.  Cure requires intimate knowledge of how and where the [[arrhythmia]] is initiated and propagated.


The SVTs can be separated into two groups, based on whether they involve the AV node for impulse maintenance or not.  Those that involve the AV node can be terminated by slowing conduction through the AV node.  Those that do ''not'' involve the AV node will not usually be stopped by AV nodal blocking manoevres.  These manoevres are still useful however, as transient AV block will often unmask the underlying rhythm abnormality.
The SVTs can be separated into two groups, based on whether they involve the AV node for impulse maintenance or not.  Those that involve the [[AV node]] can be terminated by slowing conduction through the AV node.  Those that do not involve the AV node will not usually be stopped by AV nodal blocking maneuvers.  These maneuvers are still useful however, as transient [[AV block]] will often unmask the underlying rhythm abnormality.


AV nodal blocking can be achieved in at least three different ways:
AV nodal blocking can be achieved in at least three different ways:


====Physical maneuvers====
====Acute Pharmacotherapy====
 
Another modality involves treatment with medications. Pre-hospital care providers and hospital clinicians might administer [[adenosine]], an ultra short acting AV nodal blocking agent. If this works, followup therapy with [[diltiazem]], [[verapamil]] or [[metoprolol]] may be indicated. SVT that does NOT involve the AV node may respond to other anti-arrhythmic drugs such as [[sotalol]] or [[amiodarone]].
A number of physical maneuvers cause increased AV nodal block, principally through activation of the parasympathetic nervous system, conducted to the heart by the [[Vagus nerve]]. These manipulations are therefore collectively referred to as vagal maneuver.


The best recognised of these is the Valsalva maneuver, which increases intra-thoracic pressure and affects baro-receptors (pressure sensors) within the arch of the [[aorta]]. This can be achieved by asking the patient to hold their breath and "bear down" as if straining to pass a bowel motion, or less embarrassingly, by getting them to hold their nose and blow out against it. Plunging the face into, or just drinking a glass of ice cold water is also often effective. Firmly pressing the bulb at the top of ''one'' of the carotid arteries in the neck (carotis sinus massage, stimulating carotid baro-receptors) is also effective, but not recommended for those without adequate medical training.
In pregnancy, [[metoprolol]] is the treatment of choice as recommended by the [[American Heart Association]].
 
====Drug Treatment====
 
Another modality involves treatment with medications. Prehospital care providers and hospital clinicians might administer [[Adenosine]], an ultra short acting AV nodal blocking agent. If this works, followup therapy with [[Diltiazem]], [[Verapamil]] or [[Metoprolol]] may be indicated.  SVT that does NOT involve the AV node may respond to other anti-arrhythmic drugs such as [[Sotalol]] or [[Amiodarone]].
 
In pregnancy, [[Metoprolol]] is the treatment of choice as recommended by the [[American Heart Association]].


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
 
[[Category:Needs content]]
[[Category:Electrophysiology]]
[[Category:Electrophysiology]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category: Overview complete]]
[[Category:Disease]]
[[Category:Needs overview]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 10:14, 10 June 2017

Supraventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Among the Different Types of Supraventricular Tachycardia

Differentiating Supraventricular Tachycardia from Ventricular Tachycardia

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples

Chest X Ray

Echocardiography

Cardiac Catheterization

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

2015 ACC/AHA Guideline Recommendations

Acute Treatment of SVT of Unknown Mechanism
Ongoing Management of SVT of Unknown Mechanism
Ongoing Management of IST
Acute Treatment of Suspected Focal Atrial Tachycardia
Acute Treatment of Multifocal Atria Tachycardia
Ongoing Management of Multifocal Atrial Tachycardia
Acute Treatment of AVNRT
Ongoing Management of AVNRT
Acute Treatment of Orthodromic AVRT
Ongoing Management of Orthodromic AVRT
Asymptomatic Patients With Pre-Excitation
Management of Symptomatic Patients With Manifest Accessory Pathways
Acute Treatment of Atrial Flutter
Ongoing Management of Atrial Flutter
Acute Treatment of Junctional Tachycardia
Ongoing Management of Junctional Tachycardia
Acute Treatment of SVT in ACHD Patients
Ongoing Management of SVT in ACHD Patients
Acute Treatment of SVT in Pregnant Patients
Acute Treatment and Ongoing Management of SVT in Older Population

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Supraventricular tachycardia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Supraventricular tachycardia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Supraventricular tachycardia medical therapy

CDC on Supraventricular tachycardia medical therapy

Supraventricular tachycardia medical therapy in the news

Blogs on Supraventricular tachycardia medical therapy

Directions to Hospitals Treating Supraventricular tachycardia

Risk calculators and risk factors for Supraventricular tachycardia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Medical Therapy

Acute Treatment

In general, SVT is not life threatening, but episodes should be treated or prevented. While some treatment modalities can be applied to all SVTs with impunity, there are specific therapies available to cure some of the different sub-types. Cure requires intimate knowledge of how and where the arrhythmia is initiated and propagated.

The SVTs can be separated into two groups, based on whether they involve the AV node for impulse maintenance or not. Those that involve the AV node can be terminated by slowing conduction through the AV node. Those that do not involve the AV node will not usually be stopped by AV nodal blocking maneuvers. These maneuvers are still useful however, as transient AV block will often unmask the underlying rhythm abnormality.

AV nodal blocking can be achieved in at least three different ways:

Acute Pharmacotherapy

Another modality involves treatment with medications. Pre-hospital care providers and hospital clinicians might administer adenosine, an ultra short acting AV nodal blocking agent. If this works, followup therapy with diltiazem, verapamil or metoprolol may be indicated. SVT that does NOT involve the AV node may respond to other anti-arrhythmic drugs such as sotalol or amiodarone.

In pregnancy, metoprolol is the treatment of choice as recommended by the American Heart Association.

References


Template:WikiDoc Sources